4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-20-000221
Director sold 2,000 shares at an average $435.05 ($870,093)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ALTMAN STEVEN R Director | 2020-08-10 | Sale | −513 | $431.77 | $221,495 | 44,467 | I |
| ALTMAN STEVEN R Director | 2020-08-10 | Sale | −400 | $433.57 | $173,427 | 44,067 | I |
| ALTMAN STEVEN R Director | 2020-08-10 | Sale | −7 | $434.00 | $3,038 | 44,060 | I |
| ALTMAN STEVEN R Director | 2020-08-10 | Sale | −571 | $435.70 | $248,783 | 43,489 | I |
| ALTMAN STEVEN R Director | 2020-08-10 | Sale | −125 | $437.24 | $54,655 | 43,364 | I |
| ALTMAN STEVEN R Director | 2020-08-10 | Sale | −384 | $439.31 | $168,695 | 42,980 | I |
| Open-market sales · 2,000 sh · avg $435.05 · $870,093 | |||||||
Loading xslF345X03/edgardoc.xml…